Prime Capital Investment Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-6,515
| Closed | -$859K | – | 1095 |
|
|
2025
Q1 | $859K | Buy |
6,515
+1,084
| +20% | +$143K | 0.01% | 539 |
|
|
2024
Q4 | $454K | Sell |
5,431
-1,989
| -27% | -$166K | 0.01% | 592 |
|
|
2024
Q3 | $543K | Sell |
7,420
-391
| -5% | -$28.6K | 0.01% | 568 |
|
|
2024
Q2 | $535K | Buy |
7,811
+55
| +0.7% | +$3.77K | 0.01% | 558 |
|
|
2024
Q1 | $537K | Sell |
7,756
-1,412
| -15% | -$97.7K | 0.01% | 604 |
|
|
2023
Q4 | $657K | Buy |
9,168
+2,743
| +43% | +$196K | 0.01% | 510 |
|
|
2023
Q3 | $335K | Sell |
6,425
-16,300
| -72% | -$849K | 0.01% | 556 |
|
|
2023
Q2 | $1.44M | Buy |
22,725
+7,500
| +49% | +$475K | 0.03% | 300 |
|
|
2023
Q1 | $824K | Buy |
+15,225
| New | +$824K | 0.03% | 271 |
|